轻中度慢阻肺的小气道病变:横断面研究
该横断面研究采用多分辨率CT与体视学方法,对吸烟者肺组织样本进行评估,包括肺功能正常对照及GOLD 1、2、4期慢阻肺患者。结果显示轻中度慢阻肺已出现终末与过渡细支气管数量显著减少及肺泡表面积下降,且与小气道壁增厚、管腔狭窄相关,提示小气道病变是早期病理特征。
要点
- 轻中度慢阻肺已存在终末与过渡细支气管显著丢失,早于或伴随肺气肿改变。
- 小气道数量减少与肺功能下降相关,残余小气道壁增厚、管腔狭窄。
- 轻度慢阻肺即应考虑早期疾病修饰干预。
核心结论
- 小气道病变是轻度和中度慢阻肺的病理特征,早期干预可能必要。
研究设计与样本
- 横断面分析,采用多分辨率CT成像与系统均匀抽样获取全肺或肺叶代表性组织样本。
- GOLD 1/2及对照来自肺叶或全肺切除标本,GOLD 4来自肺移植标本,共262个肺样本。
主要发现
- 与对照吸烟者相比,终末细支气管数量GOLD 1减少40%(p=0·014)、GOLD 2减少43%(p=0·036)。
- 过渡细支气管数量GOLD 1减少56%(p=0·0001)、GOLD 2减少59%(p=0·0001)。
- 肺泡表面积GOLD 1减少33%(p=0·019)、GOLD 2减少45%(p=0·0021)。
- 上述病理改变与肺功能下降相关;肺泡表面积正常的GOLD 1/2样本仍见终末和过渡细支气管显著丢失。
- 残余小气道壁增厚、管腔狭窄,随GOLD分期增加阻塞加重。
临床怎么用
- 对轻中度慢阻肺患者应关注小气道病变,考虑早期疾病修饰干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The concept that small conducting airways less than 2 mm in diameter become the major site of airflow obstruction in chronic obstructive pulmonary disease (COPD) is well established in the scientific literature, and the last generation of small conducting airways, terminal bronchioles, are known to be destroyed in patients with very severe COPD. We aimed to determine whether destruction of the terminal and transitional bronchioles (the first generation of respiratory airways) occurs before, or in parallel with, emphysematous tissue destruction. METHODS: In this cross-sectional analysis, we applied a novel multiresolution CT imaging protocol to tissue samples obtained using a systematic uniform sampling method to obtain representative unbiased samples of the whole lung or lobe of smokers with normal lung function (controls) and patients with mild COPD (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage 1), moderate COPD (GOLD 2), or very severe COPD (GOLD 4). Patients with GOLD 1 or GOLD 2 COPD and smokers with normal lung function had undergone lobectomy and pneumonectomy, and patients with GOLD 4 COPD had undergone lung transplantation. Lung tissue samples were used for stereological assessment of the number and morphology of terminal and transitional bronchioles, airspace size (mean linear intercept), and alveolar surface area. FINDINGS: Of the 34 patients included in this study, ten were controls (smokers with normal lung function), ten patients had GOLD 1 COPD, eight had GOLD 2 COPD, and six had GOLD 4 COPD with centrilobular emphysema. The 34 lung specimens provided 262 lung samples. Compared with control smokers, the number of terminal bronchioles decreased by 40% in patients with GOLD 1 COPD (p=0·014) and 43% in patients with GOLD 2 COPD (p=0·036), the number of transitional bronchioles decreased by 56% in patients with GOLD 1 COPD (p=0·0001) and 59% in patients with GOLD 2 COPD (p=0·0001), and alveolar surface area decreased by 33% in patients with GOLD 1 COPD (p=0·019) and 45% in patients with GOLD 2 COPD (p=0·0021). These pathological changes were found to correlate with lung function decline. We also showed significant loss of terminal and transitional bronchioles in lung samples from patients with GOLD 1 or GOLD 2 COPD that had a normal alveolar surface area. Remaining small airways were found to have thickened walls and narrowed lumens, which become more obstructed with increasing COPD GOLD stage. INTERPRETATION: These data show that small airways disease is a pathological feature in mild and moderate COPD. Importantly, this study emphasises that early intervention for disease modification might be required by patients with mild or moderate COPD. FUNDING: Canadian Institutes of Health Research.
引用
- Koo HK, Vasilescu DM, Booth S, et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med. 2018. PMID: 30072106. doi:10.1016/S2213-2600(18)30196-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。